The case for preventing ovarian cancer

No authors listed

Editorial

No authors listed. Lancet. 2008.

. 2008 Jan 26;371(9609):275.

doi: 10.1016/S0140-6736(08)60139-7.

No abstract available

Comment in

Ovarian cancer and oral contraceptives.
Bliziotis IA. Bliziotis IA. Lancet. 2008 May 17;371(9625):1663. doi: 10.1016/S0140-6736(08)60720-5. Lancet. 2008. PMID: 18486736 No abstract available.
Over-the-counter access to oral contraceptives.
Kishen M, Guthrie K, Robinson C, Dewart P, Elliman A. Kishen M, et al. Lancet. 2008 May 17;371(9625):1663. doi: 10.1016/S0140-6736(08)60721-7. Lancet. 2008. PMID: 18486737 No abstract available.

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
Collaborative Group on Epidemiological Studies of Ovarian Cancer; Beral V, Doll R, Hermon C, Peto R, Reeves G. Collaborative Group on Epidemiological Studies of Ovarian Cancer, et al. Lancet. 2008 Jan 26;371(9609):303-14. doi: 10.1016/S0140-6736(08)60167-1. Lancet. 2008. PMID: 18294997